-+ 0.00%
-+ 0.00%
-+ 0.00%

Cabaletta Bio Doses First Two Patients Rese-cel Manufactured on Cellares' Automated Cell Shuttle Platform

Benzinga·04/14/2026 20:32:34
Listen to the news

First two GMP doses of rese-cel manufactured on the Cell Shuttle™ met all release specifications, were delivered on time, and have been infused into patients within Cabaletta Bio's RESET™ clinical trial program.